Unternehmen Novartis AG

Unternehmen Novartis AG

904278

CH0012005267

NOVN

Pharmazeutika

Analystenschätzungen

Aktien

904278

CH0012005267

NOVN

Pharmazeutika

Analystenschätzungen

Kurzporträt

Umsatz nach Geschäftsbereich

Umsatz je Region

Manager

Aufsichtsräte

Anteilsklasse

Aktionäre

Unternehmensbesitz

Unternehmenskontakt

Konzerngesellschaften

Sektor

Umsatz nach Geschäftsbereich

Umsatz je Region

Ratings für Novartis AG

Verlauf des Gewinns je Aktie

Quartalsgewinne - Abweichungsrate

Sektor Pharmazeutika - Andere

Kurzporträt

Umsatz nach Geschäftsbereich

Umsatz je Region

Manager

Aufsichtsräte

Anteilsklasse

Aktionäre

Unternehmensbesitz

Unternehmenskontakt

Konzerngesellschaften

Sektor

Umsatz nach Geschäftsbereich

Umsatz je Region

Ratings für Novartis AG

Verlauf des Gewinns je Aktie

Quartalsgewinne - Abweichungsrate

Sektor Pharmazeutika - Andere

Markt geschlossen - Swiss Exchange Andere Börsenplätze 17:30:38 18.04.2024			% 5 Tage	% 1. Jan.
84.52 ^CHF	-0.39%		-1.30%	-0.41%

18.04.	Aktien Schweiz Schluss: SMI geht am Ende praktisch unverändert aus dem Handel	AW
18.04.	UBS belässt Novartis auf 'Buy' - Ziel 104 Franken	DP

Novartis AG zählt zu den weltweit führenden Unternehmen für Konzipierung, Herstellung und Vertrieb von Pharmaprodukten. Der Umsatz (ausgenommen aufgegebenen Geschäftsbereiche) ist wie folgt auf die verschiedenen therapeutische bereiche verteilt:

- Onkologie (29,9%);

- Immunologie (17,2%);

- Herz-Kreislauf-, Nieren- und Stoffwechselerkrankungen (14,1%);

- Neurologie (8,9%).

Der restliche Umsatz (29,9%) wird aus der Auftragsfertigung von Pharmaprodukte erzielt.

Ende 2023 verfügte die Novartis AG über 33 Produktionsstandorte auf der ganzen Welt.

Die geographische Umsatzverteilung sieht aus wie folgt: Europa (33%), USA (39,5%), Asien / Afrika / Australasien (20,5%), Kanada und Lateinamerika (7%).

Mitarbeiterzahl: 76 057

CHF in Millionen	2022	Gewichtung	2023	Gewichtung	Delta
Established Brands 30,0 %	-	-	12 238	30,0 %	-
Oncology 29,9 %	-	-	12 213	29,9 %	-
Immunology 17,2 %	-	-	7 008	17,2 %	-
Cardiovascular, Renal and Metabolic 14,1 %	-	-	5 743	14,1 %	-
Neuroscience 8,9 %	-	-	3 633	8,9 %	-

CHF in Millionen	2022	Gewichtung	2023	Gewichtung	Delta
United States 39,5 %	16 860	34,9 %	16 139	39,5 %	-4.28%
Europe 18,9 %	10 469	21,7 %	7 704	18,9 %	-26.41%
Asia/Africa/Australasia 9,1 %	4 975	10,3 %	3 700	9,1 %	-25.63%
Germany 7,4 %	4 086	8,5 %	3 026	7,4 %	-25.94%
China 7,2 %	2 987	6,2 %	2 936	7,2 %	-1.73%
Canada and Latin America 7,0 %	3 709	7,7 %	2 854	7,0 %	-23.04%
Japan 4,2 %	2 106	4,4 %	1 729	4,2 %	-17.90%
France 3,8 %	2 156	4,5 %	1 572	3,8 %	-27.09%
Switzerland 2,9 %	926	1,9 %	1 175	2,9 %	+26.88%

Manager	Titel	Alter	Seit
Vasant Narasimhan CEO	Chief Executive Officer	48	01.01.05
Harry Werner Kirsch DFI	Director of Finance/CFO	59	01.01.03
Shreeram Aradhye CTO	Chief Tech/Sci/R&D Officer	62	16.05.22
Steffen Lang COO	Chief Operating Officer	57	01.04.17
Klaus Moosmayer CMP	Compliance Officer	56	01.12.18
Samir Shah IRO	Public Communications Contact	63	01.01.04
Simon Brown PRN	Corporate Officer/Principal	-	01.08.13
Kees Roks AUD	Comptroller/Controller/Auditor	61	01.05.22
Linda Kanitra PRN	Corporate Officer/Principal	-	-
Robert Kowalski HRO	Human Resources Officer	56	01.09.21

Aufsichtsräte	Titel	Alter	Seit
Bill Winters BRD	Director/Board Member	62	01.01.13
Simon Moroney BRD	Director/Board Member	65	28.02.20
Hans Jörg Reinhardt CHM	Chairman	68	01.01.13
John Young BRD	Director/Board Member	60	07.03.23
Bridgette Heller BRD	Director/Board Member	62	28.02.20
Ton Büchner BRD	Director/Board Member	59	01.01.16
Charles Sawyers BRD	Director/Board Member	65	01.01.13
Nancy Andrews BRD	Director/Board Member	65	01.01.15
Patrice Bula BRD	Director/Board Member	68	28.02.19
Frans van Houten BRD	Director/Board Member	64	28.02.17

	Vote	Menge	Streubesitz	Konzerneigene Aktien	Total Float
Aktie A	1	2 277 477 752	1 866 336 959 ( 81,95 %)	233 443 766 ( 10,25 %)	81,95 %

Name	Aktien	%	Bewertung
NOVARTIS AG 6,625 %	145 083 991	6,625 %	14 073 Mio CHF
Sandoz Family Foundation 4,070 %	89 135 960	4,070 %	8 646 Mio CHF
UBS Asset Management Switzerland AG 3,123 %	68 391 910	3,123 %	6 634 Mio CHF
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 0,3011 %	6 593 896	0,3011 %	640 Mio CHF
State Street Global Advisors Ltd. 0,2103 %	4 604 889	0,2103 %	447 Mio CHF
UBS AG (Investment Management) 0,1782 %	3 902 170	0,1782 %	379 Mio CHF
La Mondiale SAM (Investment Portfolio) 0,1776 %	3 888 630	0,1776 %	377 Mio CHF
MFS International (UK) Ltd. 0,1769 %	3 873 030	0,1769 %	376 Mio CHF
MFS International Singapore Pte. Ltd. 0,1738 %	3 806 964	0,1738 %	369 Mio CHF
Union Investment Privatfonds GmbH 0,1659 %	3 632 402	0,1659 %	352 Mio CHF

Name	Aktien	%	Bewertung
Dodge & Cox 0,6012 %	13 165 538	0,6012 %	1 274 Mio CHF
PRIMECAP Management Co. 0,5893 %	12 905 697	0,5893 %	1 248 Mio CHF
Eaton Vance Management 0,3239 %	7 092 253	0,3239 %	686 Mio CHF
Dimensional Fund Advisors LP 0,2776 %	6 078 175	0,2776 %	588 Mio CHF
Loomis, Sayles & Co. LP 0,2744 %	6 009 900	0,2744 %	581 Mio CHF
Fiduciary Trust Company International 0,2701 %	5 915 750	0,2701 %	572 Mio CHF
U.S. Trust Company of Delaware 0,2401 %	5 258 331	0,2401 %	509 Mio CHF
Wellington Management Co. LLP 0,2167 %	4 746 599	0,2167 %	459 Mio CHF
Wells Fargo Bank NA 0,1824 %	3 994 934	0,1824 %	386 Mio CHF
The Ayco Co. LP 0,1615 %	3 535 902	0,1615 %	342 Mio CHF

Name	Aktien	%	Bewertung
LUKB Expert Fondsleitung AG -	64 694	-	6 Mio CHF
ATP Fondsmaeglerselskab A/S -	46 082	-	4 Mio CHF
Swiss Rock Asset Management AG -	19 614	-	2 Mio CHF
Niederer & Partners AG -	5 300	-	513 818 CHF
JPMorgan Asset Management (China) Co Ltd. -	2 652	-	257 103 CHF
Liontrust Portfolio Management Ltd. -	474	-	45 953 CHF

Name	Aktien	%	Bewertung
NOVARTIS AG 6,63%	145 083 991	6,63%	14 073 485 173 $
SANDOZ GROUP AG 4,30%	18 524 209	4,30%	559 613 390 $
NOVARTIS INDIA LIMITED 70,68%	17 450 680	70,68%	215 208 068 $
MORPHOSYS AG 5,37%	2 023 370	5,37%	146 848 101 $
ERASCA, INC. 8,15%	12 307 692	8,15%	25 353 846 $
THIRD HARMONIC BIO, INC. 6,49%	2 642 762	6,49%	24 947 673 $
OCULIS HOLDING AG 4,68%	1 713 521	4,68%	20 647 928 $
POSEIDA THERAPEUTICS, INC. 6,12%	5 908 089	6,12%	18 846 804 $
MOLECULAR PARTNERS AG 4,78%	1 739 130	4,78%	7 095 929 $
PRECISION BIOSCIENCES, INC. 6,30%	413 577	6,30%	5 608 104 $

Novartis AG

Lichtstrasse 35

4056, Basel

+41 61 324 1111

http://www.novartis.com

Name	Kategorie und Branche
Novartis International AG Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.	Pharmaceuticals: Major
Novartis BioVenturesAG Novartis BioVenturesAG Investment ManagersFinance Part of Novartis AG, Novartis BioVenturesAG is an alternative investment manager. The private company is based in Basel, Switzerland.	Investment Managers
NOVARTIS INDIA LIMITED	Pharmaceuticals: Major
Novartis Securities Investment Ltd. Novartis Securities Investment Ltd. Investment ManagersFinance Part of Novartis AG, Novartis Securities Investment Ltd. is an investment bank that offers investment advice. The private company is located in Bermuda.	Investment Managers
EBEWE Pharma Ges.m.b.H. Nfg.KG EBEWE Pharma Ges.m.b.H. Nfg.KG Pharmaceuticals: MajorHealth Technology EBEWE Pharma Ges.m.b.H. Nfg.KG engages in the development and manufacture of injectable pharmaceutical specialties. The firm offers therapy solutions for colon, lung, breast, and prostate cancer. It also specializes in drug and pharmaceutical development, as well as preclinical studies. The company was founded in 1934 and is headquartered in Unterach am Attersee, Austria.	Pharmaceuticals: Major
Novartis Capital Corp. Novartis Capital Corp. Finance/Rental/LeasingFinance Novartis Capital Corp. engages in the manufacture of pharmaceutical products. The company is headquartered in East Hanover, NJ.	Finance/Rental/Leasing
Novartis Finance SA	Finance/Rental/Leasing
Sandoz GmbH Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.	Pharmaceuticals: Major
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.	Pharmaceuticals: Major
Novartis Holding AG Novartis Holding AG Financial ConglomeratesFinance Part of Novartis AG, Novartis Holding AG is a Swiss healthcare company that provides solutions to address the evolving needs of patients worldwide. The private company is based in Basel, Switzerland. Novartis Holding specializes in Managed Access Programs and is committed to the discovery, development, and marketing of innovative products to improve the well-being of all Canadians. The company prides itself on its commitment to diversity and to nurturing an inclusive and inspiring environment.	Financial Conglomerates
Novartis UK Pension Scheme	Investment Managers
Novartis Investments SARL Novartis Investments SARL Financial ConglomeratesFinance Novartis Investments SARL is an investment holding company with interest in medicines and pharmaceuticals sector. The company was founded on July 05, 2002 and is headquartered in Luxembourg.	Financial Conglomerates
Novartis Investment Ltd.
Novartis Healthcare Pvt Ltd. Novartis Healthcare Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Healthcare Pvt Ltd. is an Indian company that manufactures and markets health care and nutritional products. The private company is based in Mumbai, India. The company was founded in 1997. The CEO is Sanjay Prabhakar Murdeshwar.	Pharmaceuticals: Major
Alcon Ophthalmika GmbH
Novartis Investment Ltd. (2120)
Novartis Services, Inc.
Sandoz Pvt Ltd. Sandoz Pvt Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz Pvt Ltd. is an Indian company that develops, manufactures and markets generic pharmaceutical products. The private company is based in Mumbai, India and was founded in 1995.	Pharmaceuticals: Generic
Novartis Pharma GmbH Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria.	Pharmaceuticals: Major

Trading Rating

Investment Rating

ESG Refinitiv

B-

Mehr Ratings

Verkaufen

Kaufen

Durchschnittl. Empfehlung

AUFSTOCKEN

Anzahl Analysten

Letzter Schlusskurs

92.75 USD

Mittleres Kursziel

106.7 USD

Abstand / Durchschnittliches Kursziel

+15.02%

Analystenschätzungen

Entwicklung der Schätzungen

Unternehmenstermine

	% 1. Jan.	Kap.
NOVARTIS AG	-0.41%	204 Mrd.
ELI LILLY AND COMPANY	+27.97%	676 Mrd.
NOVO NORDISK A/S	+23.58%	554 Mrd.
JOHNSON & JOHNSON	-7.02%	349 Mrd.
MERCK & CO., INC.	+14.85%	318 Mrd.
ABBVIE INC.	+6.25%	291 Mrd.
ASTRAZENECA PLC	+2.96%	210 Mrd.
ROCHE HOLDING AG	-10.02%	194 Mrd.
PFIZER, INC.	-11.81%	144 Mrd.
AMGEN INC.	-8.80%	142 Mrd.

Pharmazeutika - Andere

Gesundheitspflege

Pharmazie und Biotechnologie

Pharmazie und Biotechnologie

Pharmazeutika

Pharmazeutika - Andere